Efficacy of hyaluronic acid for recurrent aphthous stomatitis: a systematic review of clinical trials
- 20 September 2021
- journal article
- review article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 25 (12) , 6561-6570
Abstract
Objectives Recurrent aphthous stomatitis (RAS) is a very common oral mucosal disease, and its management is quite challenging with no definitive cure being available so far. Many studies have tried hyaluronic acid (HA) for alleviating signs and symptoms of RAS. The present systematic review sought to assess the available evidence regarding the efficacy of HA in management of RAS. Methods Two reviewers independently conducted extensive search in four online databases (PubMed, Scopus, Web of Science, and Google Scholar) and the gray literature, with no restriction to date or language of the publication. All clinical trials that assessed the efficacy of HA in reducing signs and symptoms of RAS were included. Risk of bias was assessed by two reviewers independently, using the Cochrane assessment tool. Due to substantial heterogeneity, no meta-analysis was feasible. Results Out of the 75 identified articles, nine clinical trials involving 538 RAS patients (259 in HA group) were included. The risk of bias was high in five studies, low in one study, and unclear in three studies. The comparative groups varied greatly across the included studies: triamcinolone (in three studies), chlorhexidine mouthwash, lidocaine, placebo, iodine glycerin, diclofenac, and laser therapy. Overall, the results revealed a good efficacy of HA in alleviating pain and shortening the healing time of RAS, without any reported side effects. Compared to triamcinolone, HA showed superior results in one study, and comparable results in two studies. Conclusions The available evidence suggests that HA is a promising treatment option for RAS. However, given the huge heterogeneity of the included studies and high risk of bias in some of these studies, the evidence is inconclusive. Further well-designed clinical trials with standardized methodologies and adequate sample sizes are warranted to discern the efficacy of HA for RAS. Clinical relevance Hyaluronic acid might be a viable alternative therapeutic option for patients with RAS.Keywords
This publication has 45 references indexed in Scilit:
- Triamcinolone Acetonide Oromucoadhesive Paste for Treatment of Aphthous StomatitisAdvanced Pharmaceutical Bulletin, 2015
- MULTI – OBJECTIVE OPTIMIZATION OF MACHINING PARAMETERS OF EN36 STEEL USING RSMInternational Journal of Research in Engineering and Technology, 2015
- Serum Th1, Th2 and Th17 cytokine profiles and alpha‐enolase levels in recurrent aphthous stomatitisJournal of Oral Pathology & Medicine, 2014
- Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee painJournal of Medical Economics, 2014
- Systemic interventions for recurrent aphthous stomatitis (mouth ulcers)Cochrane Database of Systematic Reviews, 2012
- Levels of salivary IgA in patients with minor recurrent aphthous stomatitis: a matched case–control studyClinical Oral Investigations, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's diseaseJournal of the European Academy of Dermatology and Venereology, 2007
- The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulcerationJournal of Oral Pathology & Medicine, 2006
- Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronanOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1997